Tech Center 1600 • Art Units: 1618
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18026759 | FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING | Non-Final OA | The Regents of the University of California |
| 17742390 | COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | Non-Final OA | FUJIFILM Corporation |
| 17761508 | FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES | Final Rejection | Purdue Research Foundation |
| 18257974 | ISOCYCLOSERAM FORMULATION | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 19232774 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | Final Rejection | GE HealthCare, Inc. |
| 19232766 | APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION | Final Rejection | GE HEALTHCARE LIMITED |
| 18056349 | HYPOXIA-TARGETING CONTRAST AGENT AND METHODS OF USE THEREOF | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17774136 | PET IMAGING OF CANCEROUS CELLS USING 18F-FLUOROACETATE | Final Rejection | Board of Regents, The University of Texas System |
| 18381930 | POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17641417 | ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS AND TISSUE | Final Rejection | The Johns Hopkins University |
| 18026300 | COMPOSITIONS INCLUDING MAGNETIC NANOPARTICLES AND METHODS OF USING AND MAKING THE SAME | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18151246 | SMALL HIGHLY UNIFORM NANOMEDICINE COMPOSITIONS FOR THERAPEUTIC, IMAGING AND THERANOSTIC APPLICATIONS | Non-Final OA | Regents of The University of Michigan |
| 18863312 | Nanoparticles for Delivery of Nucleic Acid Cargos | Non-Final OA | 4BASEBIO UK LTD |
| 17659953 | IRON NITRIDE NANOPARTICLE SUSPENSION | Final Rejection | Regents of the University of Minnesota |
| 18940433 | Albumin Conjugates and Process for Preparation thereof | Final Rejection | Jubilant Draximage Inc. |
| 17927917 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | Non-Final OA | UNM RAINFOREST INNOVATIONS |
| 17253307 | TRIAZAMACROCYCLE-DERIVED CHELATOR COMPOSITIONS FOR COORDINATION OF IMAGING AND THERAPY METAL IONS AND METHODS OF USING SAME | Non-Final OA | The Research Foundation for The State University of New York |
| 17912313 | SCREENING METHODS TO IDENTIFY SMALL MOLECULE COMPOUNDS THAT PROMOTE OR INHIBIT THE GROWTH OF CIRCULATING TUMOR CELLS, AND USES THEREOF | Non-Final OA | University of Southern California |
| 18241277 | SURGICAL VISUALIZATION AND MEDICAL IMAGING DEVICES AND METHODS USING NEAR INFRARED FLUORESCENT POLYMERS | Final Rejection | University of Rochester |
| 17998712 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | Final Rejection | UNIVERSITY OF COPENHAGEN |
| 17574790 | Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents | Non-Final OA | Virginia Commonwealth University |
| 17764708 | METAL CHELATING AGENTS AND METHODS OF USING THE SAME | Final Rejection | City of Hope |
| 18348811 | Ophthalmic Implant | Non-Final OA | Evonik Corporation |
| 16876109 | METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES | Final Rejection | National Taiwan University of Science and Technology |
| 18246706 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | Final Rejection | ORANO MED |
| 18158427 | METHODS AND SYSTEMS FOR SPATIALLY IDENTIFYING ABNORMAL CELLS | Non-Final OA | Lumicell, Inc. |
| 18216888 | PHARMACEUTICAL COMPOSITIONS OF CHEMOTHERAPEUTIC AGENTS BASED ON BETA-SUBSTITUTED BETA-AMINO ACID DERIVATIVES | Non-Final OA | QUADRIGA BIOSCIENCES, INC. |
| 16998587 | TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE | Final Rejection | On Target Laboratories, LLC |
| 18116976 | Methods and Apparatuses for the Synthesis of Drug-Loaded Magnetic Micelle Aggregates | Non-Final OA | Imagion Biosystems, Inc. |
| 18023526 | TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING | Non-Final OA | Zhejiang Haibo Biotech, Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy